Researchers found the PHGDH gene directly causes Alzheimer’s and discovered a drug-like molecule, NCT-503, that may help ...

A new study has found that a common class of medications could dramatically decrease the risk of developing the neurodegenerative disorder.

In a recent study, researchers found adverse events were rare and manageable among clinic patients with very mild or mild Alzheimer's disease who received lecanemab infusions.

The Food and Drug Administration's approval in 2023 of lecanemab - a novel Alzheimer's therapy shown in clinical trials to modestly slow disease progression - was met with enthusiasm by many in the ...

The Food and Drug Administration's approval in 2023 of lecanemab—a novel Alzheimer's therapy shown in clinical trials to ...

In an executive order Monday morning, Trump announced plans to reduce drug prices by 30 to 80%.

A world-leading experimental dementia drug designed to prevent the disease before it begins will be trialled in Australia for ...

A team of Australian scientists has identified a small molecule that blocks cell death, an advance that could lead to new ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50 per cent more weight than those using rival Novo Nordisk's Wegovy.

Researchers have discovered how to block cells dying, in a finding that could lead to new treatments for neurodegenerative ...